GOOD ASSETS
ADVENTA 7191 Share Price
RM0.12
klse: Adventa Berhad
Stock Information
Board : Main
Shariah : Shariah Compliant
Sector : Healthcare Products Hospital or Centre
Address: No. 21, Jalan Tandang, 51/205A, Seksyen 51, Petaling Jaya, 46050, Selangor
Contact: +603-92130520
Website: https://www.adventa.com.my/
Stock Background
Adventa Berhad is manufactures and distributes sterile surgical and medical examination gloves as well as distributes medical and hospital related products. Adventa also generates and supplies energy and electricity using biomass technology.
Profit Analysis: ADVENTA 7191
|
Result
Quarter Report History
| Date | Revenue,k | PBT,k | Net Profit,k |
|---|---|---|---|
| 29/05/26 | 10,176 | -1,927 | -1,971 |
| 27/02/26 | 14,032 | -4,815 | -6,385 |
| 25/11/25 | 11,758 | 178 | 172 |
| 26/08/25 | 13,937 | 431 | 438 |
| 20/05/25 | 13,564 | 308 | 313 |
| 28/02/25 | 17,032 | 798 | 788 |
| 29/11/24 | 15,419 | 662 | 658 |
| 26/08/24 | 12,348 | 345 | 342 |
| 02/05/24 | 13,503 | 301 | 301 |
| 27/02/24 | 8,647 | -4,578 | -3,453 |
| 28/11/23 | 8,117 | -1,994 | -1,941 |
| 29/08/23 | 6,661 | -2,559 | -2,539 |
Fundamental
Fundamental Analysis
| Last 4 Quarter Revenue (RM’000) | 50 |
|---|---|
| Last 4 Quarter Net Profit (RM’000) | -7,737 |
| Last 4 Quarter EPS (sen) | -2.54 |
| Last 4 Quarter PER | 0 |
| Last 4 Quarter Dividend (sen) | – |
| Last 4 Quarter Dividend Yield (%) | 0.00 |
| Net Tangible Assets (RM) | 0.29 |
| Goodwill (RM) | 55 |
| Cash (RM’000) | 7,260 |
| Debt (RM’000) | 17,240 |
| Total Debt (RM’000) | 19,680 |
| Net Assets (RM’000) | 84,400 |
| Current Ratio | 4.61 |
| Quick Ratio | 3.15 |
| Cash Ratio | 1.20 |
Technical
Technical Analysis
| MACD (26 vs 12) | -0.063 |
|---|---|
| Exponential Moving Average 5 | 0.123 |
| Exponential Moving Average 20 | 0.121 |
| Exponential Moving Average 90 | 0.135 |
| Relative Strength Index 14 | 0.60 |
| Stochastic %D 3 | 0.67 |
| Stochastic %K 14 | 1.00 |
10 reviews for ADVENTA 7191
Show all Most Helpful Highest Rating Lowest Rating
Only logged in customers who have purchased this product may leave a review.
Stock Profit Analysis
-
BNASTRA 7195 ★★★★★RM2.14 - PETRONM 3042 ★★★★★RM3.44
- CMSB 2852 ★★★★★RM1.00
- SUNREIT 5176 ★★★★★RM2.23
Salary Proof
BURSA MALAYSIA –
The Group is reporting a net loss before tax of RM4.8 million for the financial year ended 31 December 2022 compared to a net profit before tax of RM7.6 million for the previous year mainly due to lower revenue. Moving forward, while they continue to pursue a strategy of expanding the product portfolio with their in-house brand of hospital and surgical disposable supplies under the Connecx name, the Group had also, on 13th January 2023 announced the proposed acquisition of industrial land in Central Jawa, Indonesia containing an area of approximately 32,400 square meters with the intention of constructing a manufacturing facility for the medical equipment industry targeting the vast Indonesian and ASEAN markets. This is seen as an inevitable step for the Group to move up the value chain of its primary trading and distribution business so as to secure its long-term business prospects.
BURSA MALAYSIA –
This quarter recorded a decrease in revenue of 53% compared to the previous quarter and a loss before tax of RM2.3m compared to a profit of RM269 thousands. Caught by the supply chain disruption, the Company is faced with challenges in catering to customer’s on-demand supply request. This has added intensity to price competitive selling resulting in lower sales revenue and margins recorded in the third quarter. Furthermore, in line with the company business diversification into product development, the development cost of the medical consumable parts produced by the Company has also added to the cost of the company.
BURSA MALAYSIA –
This quarter recorded increase in revenue of RM3.6 million compared to the previous quarter and a lower profit before tax by RM641 thousand. The country attained the National Covid-19 Immunization Programme target and entered endemic phase. This has led to the closure of PPV centers and shift in demand and usage of personal protective equipment (“PPE”) range. While sales for these products declined, the demand for operating room related products has increased which resulted in 20% improvement in sales revenue in this quarter. However the elevated cost pressure from surging raw material cost and higher freight charges affected the margin in this quarter.
BURSA MALAYSIA –
This quarter recorded a drop in revenue of RM4.3 million compared to the previous quarter and a lower profit before tax by RM1.79 million. In the current quarter, there is a change in hospitals’ protocols and health policies as the country gradually embraces endemicity and we saw a shift in demand and usage of selected hospital products especially the personal protective equipment range. The closure of Mega Vaccination Centers has resulted in slower offtake of vaccination related supplies.
BURSA MALAYSIA –
This quarter recorded a drop of 48% in revenue and a 32% decrease in profit before tax compared to the previous quarter, mainly due to the massive flash floodsin December that disrupted the supply chain.
BURSA MALAYSIA –
Compared to the previous quarter, this quarter sees a small but strategic improvement of 2% in revenue and a significant 86.5% decrease in loss. The previous quarter’s result includes a provision of RM6 million impairment of trade receivables. Ignoring this factor, the result still shows a trading improvement over the previous quarter, with the hospital products distribution segment contributing positively to the Group results.
BURSA MALAYSIA –
Revenue for 2Q 2020 was RM 46.37 million, a 337% increase compared to RM 1Q 2020 at RM 13.7m. The increase in revenue was contributed by the sales of PPE and other medical consumables linked to the Covid-19 pandemic and the effect of the movement controls.
REMUNERATION STUDY –
In Financial Year End 2019, the directors’ remuneration was 1.24 million. It was fair compared to average in listed companies, considering the employees’ remuneration of 8 million and auditor’s remuneration of 135 thousands
BURSA MALAYSIA –
Revenue for 1Q 2020 was RM 13.67 million, an increase of 17% compared to RM 11.64 million in 4Q 2019. The increase in revenue was mainly contributed by the sales of PPE amid Covid-19 pandemic. Profit before tax and EBITDA reported improvement in current quarter were mainly due to better profit margin from the sales of PPE; Deferred development cost of home dialysis products was written off; Impairment of trade receivables.
Investing Malaysia –
Average investing volume for Adventa Bhd in the past three months in stock market was 245.1k lots
Investing Malaysia –
ADVENTA gets a score of 9.87 in our equity and assets quality test based on current share price of RM0.645
Investing Malaysia –
Adventa Bhd gets a score of 16.8 in our stability test after the balance sheet, money statement study
Investing Malaysia –
Stock code of 7191 in Bursa Malaysia did not propose any dividend for the past few years
Investing Malaysia –
ADVENTA is forecasted to made loss of 0.83 millions, with an adjusted market capitalization of 96.26 millions
REMUNERATION STUDY –
In Financial Year End 2018, the directors’ remuneration was 1.64 million. It was fair compared to average in listed companies, considering the employees’ remuneration of 8.4 million and auditor’s remuneration of 155 thousands